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and we show for different scenarios how close the estimates come. For selected 
treatment comparisons we present effect-sizes with confidence intervals. We apply 
also the Bayesian extension and discuss its advantages. ConClusions: Based on 
our research we give recommendations of when the Lumley-method should be best 
applied, and discuss limitations.1 Lumley T: Network meta-analysis for indirect 
treatment comparisons. Stat. Med. 2002; 21: 2313-2324.
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objeCtives: Evaluation and comparison of oral antidiabetic drugs (OAD) consump-
tion at state level are an important element at control of 2ndtype DM patients treat-
ment quality. The objective of the study is to determine the volumes and structure 
of OAD consumption in Ukraine and to compare it with consumption in the other 
countries. Methods: ATC/DDD-methodology with application of DDD/1000/day 
(DID). The evaluation is based on consumption volume, provided by “PharmXplorer/
Pharmstandard” analytical system of market research. Results: In year 2008, OAD 
consumption in Ukraine was 5.78 DID and increased to 11.13 DID in year 2013. In 
year 2011, OAD consumption was 54.28 DID in France, 44.58 - in Germany (S. Pichetti, 
C. Sermet, S. van der Erf, 2013), 33.25 - in Estonia, 29.87 - in Latvia (Baltic Statistics 
on Medicines 2010–2012), showing that OAD consumption in Ukraine was very low. 
Structure of OAD consumption in Ukraine shows that 98.95% of the total consump-
tion volume is distributed to 2 groups: sulfonylureas (73.84%) and biguanides (25%) 
and only 1,05% to gliptines, glitazones, glucosidases and glinides. The total share 
of preparations of sulfonylureas and biguanides group in the total consumption 
structure in France and Germany was 71.8% and 80.1% respectively of the total 
consumption OAD. In year 2013, OAD of the II generation - gliclazide (3.01 DID) and 
glibenclamide (2,09 DID) had the highest consumption level in sulfonylureas group, 
preparations of III generation - glimepiride (2,09 DID) had lesser consumption rate. 
Out of 61 OAD trade names (TN), presented in the pharmaceutical market of Ukraine, 
8 TNs took 89.78% of the total consumption volume. ConClusions: Very low rate 
of OAD consumption in Ukraine shows the necessity of its increase. Analysis of OAD 
consumption structure evidences the application of relatively cheap and long-used 
medical preparations for treatment of 2nd type DM, which is largely due to financial 
capacities of payers.
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objeCtives: In the context of uncertainty due to the lack of sound data, expert 
opinion is considered as a legitimate source of information for decision-makers. 
The use of experts’ opinion requires to quantifying their uncertainty about a specific 
event by eliciting a probability distribution of the event. The objectives of this study 
were to develop a web-based tool enabling users to remotely elicit the opinion of a 
group of geographically dispersed experts and to evaluate the measurement prop-
erties of this tool. Methods: The web-based tool allowed first to elicit univariate 
probability distributions separately from each expert and secondly to calculate an 
aggregated distribution. The elicitation method was the four-interval method that 
was judged to be more appropriate for non-statistician experts due to its clarity 
of use. As recommended to limit biases, the elicitation questionnaire included a 
training exercise and a graphical feedback so that the experts could validate their 
distributions. A pilot survey was conducted among all the French regional medical 
device vigilance correspondents (n= 24) about the risk of failure (%) of an implantable 
medical device. Results: Twenty-two correspondents (92%) completed the survey. 
An aggregated distribution was calculated from the elicited individual distributions 
and a beta distribution was fitted reflecting the group uncertainty about the risk of 
failure. Feasibility was judged in view of the users’ feedback and time to completion. 
Validity and reliability were assessed using data on comprehensiveness, internal 
coherence and test-retest reliability. ConClusions: The proposed web-based tool 
was feasible, valid and reliable. It should be useful in making expert elicitation 
easier and more practical.
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objeCtives: The main objective of the study is to promote awareness and assess 
the knowledge of adolescents on medication use, importance of balanced diet and 
physical activity. Methods: The study was conducted among the adolescents 
aged from16-18 years in Regions of Guntur. The volunteers are allowed to fill their 
informed consent to be a part of the study. The questionnaire was distributed to all 
the volunteers included in the study, which includes questions on their medica-
tion taking behaviour, dietary habits and physical activity. The response was then 
analyzed to assess the knowledge on medication use, balanced diet and physical 
activity. Results: Among the 165 individuals on assessment of their medication 
taking behavior78% of them do not follow their prescription, 61% of the individuals 
do not have any idea on their medication use and a majority of 74% are not aware 
of the unwanted effects caused by the medication. On assessment of their dietary 
habits and physical activity, 62% of the individuals include meal rich in fat, 42% 
of the individuals skip their breakfast every day and 41% of them will not include 
leafy vegetables as part of their regular meal. 65% of individuals do not perform a 
regular physical activity ConClusions: It is the responsibility of the pharmacist 
in a user-friendly environment during a decision-making setting avoiding disad-
vantages of pre-prepared analyses.
PRM196
An eVAluAtion And coMPARison of Methods used in suRViVAl 
AnAlysis to fit distRibutionAl cuRVes to kAPlAn-MeieR dAtA
Haines P.
Curo, Marlow, UK
objeCtives: HTA bodies increasingly require accurate survival estimates in order to 
provide reliable recommendations. It is argued that access to individual patient data 
(IPD) can improve their accuracy. This paper aims to assess to what degree extract-
ing IPD from published Kaplan-Meier curves helps improve extrapolated survival 
estimates. Some methods currently used for HTA submissions fit a survival curve 
directly to a published Kaplan-Meier curve, but does this lack accuracy? Methods: 
Two methods used to extract the IPD from Kaplan-Meier curves reviewed in this 
paper are by Guyot et al (Guyot, Ades, Ouwens, & Welton, 2012) and Hoyle and 
Henley (Hoyle & Henley, 2011) which were compared against the outcomes of the 
standard ‘least squares’ method. Comparisons were made for two situations: 1) 
when numbers at risk are available at different time points throughout the Kaplan-
Meier curve and 2) when numbers at risk are only available at the start. Results: 
The three methods resulted in the long-normal distribution showing the best fit, 
with all containing the true mean and median within their confidence intervals. 
However, the Hoyle and Henley method estimates a mean marginally closer to the 
true mean than the other methods in both situations. When many numbers at risk 
are provided, the Hoyle and Henley method gives narrower confidence intervals. 
Both extraction methods slightly outperformed the least squares method. The three 
methods give median estimates and resulting confidence intervals which are statis-
tically equivalent to that of the IPD, except for the Guyot method when numbers at 
risk are not available. ConClusions: In conclusion, extraction methods can give 
marginally better results than the Least Squares method. However, these results 
may not be applicable to other examples. In addition, the extra time taken to run 
extraction methods could be too large to account for the small improvement in 
accuracy of results.
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objeCtives: A frequent challenge in Network Meta-Analysis (NMA) arises from the 
fact that several interventions may belong to the same class and be given at multiple 
doses. Models have been proposed for NMA accounting for dose-response, but these 
models do not also consider class effects at the same time, which are important 
from a decision making perspective. We aim to develop a framework that extends 
dose-response NMA methods to account for dose and class effects simultaneously, 
and explore the ability of these models to explain heterogeneity, improve model fit 
and increase precision of the estimated treatment effects. Methods: Using clini-
cal trial data of treatments for acute migraine obtained from Cochrane reviews, we 
developed multi-level NMA models to simultaneously account for dose-response 
and class-effects, in particular defining a ‘dose’, ‘treatment’ and ‘class’ hierarchy 
within the NMA models. We explored a non-parametric “random walk” model con-
strained to be monotonically increasing with dose. Multi-level NMA models were 
compared to 1-level (standard) NMA models where interventions were ‘lumped’ at 
each level separately. Results: The model that explicitly included monotonic dose-
response and class effects showed the best fit and least heterogeneity, and produced 
more precise measures of treatment effect than all 1-level models. NMA models that 
made less plausible assumptions around dose-response had poorer fit than models 
with monotonic dose-response. ConClusions: We have developed a framework 
for simultaneously estimating treatment effects at the ‘dose’, ‘treatment’ and class 
level within the same NMA model. The framework can help decision makers iden-
tify the most appropriate class, drug, and dose, however, results of dose-response 
models are not straightforward to interpret or implement from a decision making 
perspective. Careful consideration should be given to dose-response and similarity 
of interventions when conducting NMA.
PRM198
the luMley-Method, A RecoMMended netWoRk MetA-AnAlysis foR 
indiRect coMPARisons, suMMARized foR PRActitioneRs
Petto H.1, Kadziola Z.1, Belger M.A.2
1Eli Lilly Regional Operations GmbH, Vienna, Austria, 2Eli Lilly and Company, Windlesham, UK
objeCtives: In recent years we have seen a growth in the use of network meta-
analysis as part of the evidence base for Health Technology Assessments, with the 
Lumley method, published in 20021being a key reference when considering both 
indirect and direct comparisons. Unfortunately the program-code included in the 
manuscript cannot easily be run, and the given examples cannot be replicated, 
even with corrected code. To give practitioners helpful insight into the method, 
we start from individual patient data of head to head trials and show how from 
subsequent data-aggregation the Lumley-model (a random-effects model) can be 
derived. Methods: We give more details than in the article of how the proposed 
variance function aggregates study-heterogeneities and of how effect-sizes and 
confidence intervals can be derived from the parameter- and variance-estimates. 
We discuss why dependencies coming from the network-structure should be incor-
porated into confidence-interval calculations and of how the model can be extended 
with an in the article suggested Bayesian approach for modeling the random-effects 
parameters. Results: We include an example of how the Lumley-method can be 
applied in practice. We present based on the program-example in the article a cor-
rected R-version and a translation into SAS. For both we show how aggregated 
study-data should be structured and dummy-coded before running the program. 
The Lumley-method was applied to simulated data with known model-parameters 
